The largest database of trusted experimental protocols

32 protocols using human fgf2

1

FGF2-driven Chondrosarcoma Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat ChondroSarcoma cells (RCS) were kindly provided by Dr Claudio Basilico from New York University School of Medicine. Cells were maintained in DMEM high glucose (Gibco) supplemented with 10% hiFBS (Gibco) and 1% Penicillin/Streptomycin/Glutamine (Gibco). For proliferation assay, 2500 cells were plated in black 96-well plate with optical bottom (Nunc). 24h after plating, medium was removed and replaced by assay medium (DMEM high glucose, 1% heat inactivated fetal bovine serum, 1% Penicillin/Streptomycin/Glutamine). Cells were either stimulated for 48h with increasing concentrations of human FGF2 (Peprotech) or 0,3ng/mL human FGF2 and increasing concentrations of Recifercept, both supplemented with 1μg/mL heparin sodium salt. Cell proliferation was assessed by measuring cell nuclei number with CyQuant Direct assay (Thermofisher Scientific). Fluorescence was measured with a Varioskan Lux plate reader.
+ Open protocol
+ Expand
2

Culturing Mouse Neural Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse embryos were harvested at E14.5, and the dorsolateral forebrain was dissected and enzymatically triturated to isolate a population of cells enriched in NPCs as previously described. NPCs isolated from a single brain were suspension-cultured in a T25 tissue culture flask in proliferation medium containing human EGF (10 ng ml-1), human FGF2 (20 ng ml-1) (Invitrogen, Carlsbad, CA), N2 supplement (1%) (GIBCO), penicillin (100 U ml-1), streptomycin (100 mg ml-1), and L-glutamine (2 mM) for 5 days and were allowed to proliferate to form neurospheres.
+ Open protocol
+ Expand
3

Establishment and Infection of Neurosphere Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare a neurosphere culture, the subventricular zone was dissected from neonatal mice and enzymatically dissociated with 0.25% trypsin and bovine DNase-I. Cells were passed through a 70 µm cell strainer followed by a 40 µm cell strainer and then plated with proliferation media consisting of neurosphere basal media (low-glucose DMEM, F12, HEPES, penicillin/streptomycin) supplemented with B27, mouse EGF, and human FGF2 (Invitrogen). To induce differentiation of neurospheres, growth factors were removed and N2 was added to the neurosphere basal media along with B27. Neurospheres were re-fed every 48 hr and used for up to 12 passages.
To infect neurospheres with LCMV, the cells were first plated in 24-well plates at a density of 125,000 cells/well on poly-d-lysine/laminin-coated coverslips (Invitrogen). The virus was diluted in neurosphere basal media and used to infect cells at 1 M.O.I. Infected cell cultures were incubated in a BSL-II primary tissue culture incubator at 37°C with 5% CO2. To perform quantitative immunocytochemistry, cell cultures were fixed for 15 min at room temperature in 4% PFA and incubated in primary antibodies for 1 hr at room temperature. Secondary antibodies were then added for 1 hr at room temperature.
+ Open protocol
+ Expand
4

Isolation and Culture of Murine Skeletal Muscle Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experimental procedures were performed according to the protocol (SCH16-0029) approved by Soonchunhyang University Animal Care and Use Committee. Quiescent SkMSCs (CD31-, CD45-, and Sca-1-negative and integrin α7-positive) were isolated from hindlimb muscles of 6- to 8-week-old ICR mice by magneticactivated cell sorting as previously described (15 (link)). The isolated quiescent SkMSCs were immediately seeded and cultured in growth medium (Ham-F10, 20% horse serum, 1% penicillin-streptomycin, 5 ng/mL of human FGF2 (PeproTech, Rocky Hill, NJ, USA) in 5% CO2 incubator at 37°C.
SkMSCs at exponential growth phase were prepared from the gastrocnemius muscle of 6- to 8-week-old ICR mice as previously described (16 (link)). SkMSCs were plated on Matrigel-coated culture dishes and cultured until 70~80% confluence in AmnioMAX-II complete medium (Thermo Fisher Scientific, Waltham, MA, USA). Cells were detached from culture plates with 0.05% trypsin and preplated for 10 min in an uncoated cell culture dish to remove fibroblasts before seeding for experiments. Myogenic differentiation was induced using Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 2% heat-inactivated horse serum.
+ Open protocol
+ Expand
5

Stem Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
ESCs were grown on gelatin-coated plates in 2i media: 1:1 neurobasal and Dulbecco’s Modified Eagle’s Medium (DMEM)/F12, supplemented with 0.5× N2 (Thermo Scientific, #17502048), 0.5× B27 (Thermo Scientific, #17504044), 0.05% BSA (Thermo Scientific, #15260037), 1 mM PD0325901 (Stemcell Technologies, #72182), 3 μM CHIR99021 (Miltenyi Biotec, #130-103-926), 2 mM L-glutamine, 0.15 mM monothioglycerol, 100 U/ml LIF. NSCs were grown on laminin-coated (Sigma Aldrich, #L2020) plates in DMEM/F12 medium supplemented with 2 mM L-glutamine, 0.5× N2, B27, glucose, BSA, HEPES, and 10 ng/ml of both mouse EGF (Peprotech, #315-09) and human FGF-2 (Peprotech, #100-18B). MEFs were cultured in DMEM supplemented with 10% fetal bovine serum (FBS).
+ Open protocol
+ Expand
6

Generation and Characterization of Knockout Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nox1 KO, Mapk14f/f, and Mapk7f/f conditional KO mice were generated as described previously (Nishida et al, 2004 (link); Matsuno et al, 2005 (link); Wang et al, 2006 (link)). These mice were crossed with transgenic Gt (ROSA)26Sortm1(EYFP)Cos mice (designated R26R-Eyfp; a gift from Dr. F Costantini, Columbia University Medical Center, New York, NY) to introduce a donor cell marker for transplantation experiments. GS cells from a transgenic mouse line of B6-TgR(ROSA26)26Sor mice (designated ROSA) (Jackson Laboratory) were previously described (Kanatsu-Shinohara et al, 2003 (link)), and GS cells were derived from Mapk14f/f and Mapk7f/f conditional KO mice using culture medium based on Iscove’s modified MEM (Invitrogen), which was supplemented with 10 ng/ml human FGF2, 15 ng/ml recombinant rat GDNF (both from Peprotech), and 1% FBS, as described previously (Kanatsu-Shinohara et al, 2014 (link)). Cultures were maintained on mitomycin C–treated mouse embryonic fibroblasts (MEFs). Where indicated, hydrogen peroxide (30 μM) or NAC (0.5 mM; Sigma) was added to the cultures. The chemicals used in the study are listed in Table S7. FGF2 and GDNF are supplemented in the medium unless stated otherwise.

Table S7 Chemicals used in this study.

+ Open protocol
+ Expand
7

Neuronal Cell Culture Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neurobasal medium, 2% B27 supplement, 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin, 20 ng/ml human FGF2 and 20 ng/ml human PDGF-AA (PeproTech).
+ Open protocol
+ Expand
8

Protein and Inhibitor Use in Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following recombinant proteins and chemical inhibitors were used: Human FGF7 (100‐19, PeproTech Inc., Rocky Hill, NJ or R&D Systems, Minneapolis, MN), human FGF10 (100‐26, PeproTech Inc.), human FGF2 (100‐18, PeproTech Inc.), human IFN‐α (300‐02AA, PeproTech Inc), FGFR1/2/3 inhibitors AZD4547 (S2801, Selleckchem, Houston, TX) and BGJ398 (NVP‐BGJ398; S2183, Selleckchem), PI3K inhibitor LY294002 (InvivoGen, San Diego, CA), AKT1/2 inhibitor A6730 (A6730, Sigma, Munich, Germany), Mek1/2 inhibitor U0126 (662005, Calbiochem, San Diego, CA), PLC‐γ inhibitor U73122 (1278, Tocris, Bristol, UK), and proteasome inhibitors MG132 (S2619 Selleckchem), bortezomib (PS‐341) (S1013, Selleckchem), and epoxomicin (E3652, Sigma).
+ Open protocol
+ Expand
9

Establishment and Culture of Germ Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
GSCs were established from 7- to 10-day-old DBA/2 pup testes, as described previously (Kanatsu-Shinohara et al., 2003 (link)). The cells were cultured in Iscove's modified Dulbecco's medium (Invitrogen, Carlsbad, CA), which was supplemented with 10 ng/mL human FGF2, 15 ng/mL recombinant rat GDNF (both from Peprotech, London, UK), and 1% fetal bovine serum (FBS) (Kanatsu-Shinohara et al., 2014b (link)). We also used a GSC line transfected with pCAG-Egfp2 as a control (Kanatsu-Shinohara et al., 2005a (link)). Cultures were maintained on mitomycin C-treated MEFs. G418 treatment was carried out as described previously (Kanatsu-Shinohara et al., 2005a (link)).
+ Open protocol
+ Expand
10

Establishment and Culture of GS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
GS cells were established from B6/Tg14 (act-EGFP-OsbY01) mice (a gift from Dr M Okabe, Osaka University, Japan) or B6-TgR (ROSA26)26Sor (ROSA; The Jackson Laboratory) mice that were backcrossed to a DBA/2 background for at least 7 generations [5 (link), 19 (link)]. GS cells from Trp53 KO mice were previously described [20 (link)]. We also derived Rb1flox/flox GS cells from 4- to 5-day-old Rb1flox/flox mice, which were produced by mating F1 offspring that resulted from crossing of Rb1flox/+ mice in a B6 background to ICR mice. AxCANCre was added to these cells at MOIs of 2.0 to produce Rb1 KO GS cells. AxCANLacZ (RIKEN BRC) was used as a control. The conditions of GS cell culture using StemPro-34 SFM (Invitrogen, Carlsbad, CA, USA) were described
previously [5 (link)]. The growth factors used were 10 ng/ml human FGF2 and 15 ng/ml rat GDNF (Peprotech, Rocky Hill, NJ, USA). The cells were maintained on mitomycin C (Sigma)-treated MEFs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!